دورية أكاديمية

Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.

التفاصيل البيبلوغرافية
العنوان: Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
المؤلفون: Shibata N; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Hasegawa Y; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Yamada K; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Kobayashi H; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Purevsuren J; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Medical Genetics Laboratory, National Center for Maternal and Child Health, Khuvisgalchdyn Street, Bayangol District, Ulaanbaatar 16060, Mongolia., Yang Y; Department of Pediatrics, Peking University First Hospital, No.1, Xi-an-men Road, Xicheng District, Beijing 100034, China., Dung VC; Center for Newborn Screening and Rare Disease, Department of Medical Genetics Metabolism and Endocrinology, Vietnam National Children's Hospital, No.18/879, La Thanh Road, Dong Da District, Hanoi, Viet Nam.; Department of Pediatrics, Hanoi Medical University. Hanoi, Viet Nam., Khanh NN; Center for Newborn Screening and Rare Disease, Department of Medical Genetics Metabolism and Endocrinology, Vietnam National Children's Hospital, No.18/879, La Thanh Road, Dong Da District, Hanoi, Viet Nam.; Department of Pediatrics, Hanoi Medical University. Hanoi, Viet Nam., Verma IC; Institute of Medical Genetics & Genomics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, India., Bijarnia-Mahay S; Institute of Medical Genetics & Genomics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, India., Lee DH; Department of Pediatrics, Soon Chun Hyang University Hospital, 59, Daesagwan-ro, Yongsan-gu, Seoul 04401, Republic of Korea., Niu DM; Institute of Clinical Medicine, National Yang-Ming University, Medical Science & Technology Building 8F, No.201, Sec.2, Shih-Pai Road, Taipei 112, Taiwan, ROC., Hoffmann GF; Department of Pediatrics, University of Heidelberg, University Children Hospital, Im Neuenheimer Field 669, Heidelberg D-69120, Germany., Shigematsu Y; Department of Pediatrics, School of Medical Sciences, University of Fukui, 23 Shimogogetsu, Matsuoka, Eiheiji-cho, Fukui 910-1193, Japan., Fukao T; Department of Pediatrics, Graduate School of Medicine, Gifu University, 1-1, Yanagido, Gifu 501-1194, Japan., Fukuda S; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Taketani T; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Yamaguchi S; Department of Pediatrics, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.
المصدر: Molecular genetics and metabolism reports [Mol Genet Metab Rep] 2018 May 21; Vol. 16, pp. 5-10. Date of Electronic Publication: 2018 May 21 (Print Publication: 2018).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101624422 Publication Model: eCollection Cited Medium: Print ISSN: 2214-4269 (Print) Linking ISSN: 22144269 NLM ISO Abbreviation: Mol Genet Metab Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York, NY] : Elsevier Inc., [2014]-
مستخلص: Background: Expanded newborn screening (ENBS) utilizing tandem mass spectrometry (MS/MS) for inborn metabolic diseases (IMDs), such as organic acidemias (OAs), fatty acid oxidation disorders, (FAODs), and amino acid disorders (AAs), is increasingly popular but has not yet been introduced in many Asian countries. This study aimed to determine the incidence rates of OAs, FAODs, and AAs in Asian countries and Germany using selective screening and ENBS records.
Materials and Methods: Selective screening for IMDs using gas chromatography-mass spectrometry and MS/MS was performed among patients suspected to be afflicted in Asian countries (including Japan, Vietnam, China, and India) between 2000 and 2015, and the results from different countries were compared. Similarly, ENBS results from Japan, South Korea, Taiwan, and Germany were compared. Additionally, the results of selective screening and ENBS in Japan were compared.
Results: Among 39,270 patients who underwent selective screening, IMDs were detected in 1170. Methylmalonic acidemia was frequently identified in several countries, including Japan (81/377 diagnosed IMDs), China (94/216 IMDs), and India (72/293 IMDs). In Vietnam, however, β-ketothiolase deficiency was particularly frequent (33/250 IMDs). ENBS yielded differences in overall IMD rates by country: 1:8557 in Japan, 1:7030 in Taiwan, 1:13,205 in South Korea, and 1:2200 in Germany. Frequently discovered diseases included propionic acidemia (PPA) and phenylketonuria (PKU) in Japan, 3-methylcrotonyl-CoA carboxylase deficiency (MCCD) and PKU in Taiwan, MCCD and citrullinemia type I in South Korea, and PKU and medium-chain acyl-CoA dehydrogenase deficiency in Germany. Furthermore, in Japan, selective screening and ENBS yielded respective PPA frequencies of 14.7% and 49.4% among all organic acidemias.
Conclusion: The incidence rates of IMDs vary by country. Moreover, the disease spectra of IMDs detected via selective screening differ from those detected via ENBS.
References: Clin Chim Acta. 2005 Apr;354(1-2):167-80. (PMID: 15748614)
Mol Genet Metab. 2010 May;100(1):37-41. (PMID: 20156697)
Brain Dev. 2005 Jan;27(1):39-45. (PMID: 15626540)
Indian J Pediatr. 2015 Jan;82(1):61-70. (PMID: 25482213)
N Engl J Med. 2003 Jun 5;348(23):2304-12. (PMID: 12788994)
J Inherit Metab Dis. 2007 Aug;30(4):507-14. (PMID: 17347912)
J Inherit Metab Dis. 2017 Mar;40(2):209-218. (PMID: 28054209)
Mol Genet Metab. 2012 Sep;107(1-2):237-40. (PMID: 22796001)
Ann Acad Med Singapore. 2008 Dec;37(12 Suppl):120-3. (PMID: 19904473)
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Aug 25;776(1):39-48. (PMID: 12127323)
J Child Neurol. 2006 Dec;21(12):1020-4. (PMID: 17156691)
Indian J Pediatr. 2011 Aug;78(8):953-60. (PMID: 21416125)
Mol Genet Metab. 2004 Apr;81(4):335-42. (PMID: 15059621)
Mol Genet Metab. 2016 Dec;119(4):322-328. (PMID: 27856190)
J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S295-305. (PMID: 20567911)
Lancet. 1991 Aug 31;338(8766):552-3. (PMID: 1678810)
J Hum Genet. 2005;50(7):338-46. (PMID: 16059747)
Hum Genet. 2002 Aug;111(2):161-5. (PMID: 12189489)
Nat Genet. 1994 Oct;8(2):122-8. (PMID: 7842009)
Hum Genet. 2001 May;108(5):404-8. (PMID: 11409868)
Genet Med. 2005 May-Jun;7(5):339-43. (PMID: 15915086)
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S435-42. (PMID: 20924684)
Hum Mutat. 2005 Oct;26(4):285-90. (PMID: 16134170)
JIMD Rep. 2012;6:79-83. (PMID: 23430943)
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):383-9. (PMID: 16763906)
Semin Perinatol. 2015 Apr;39(3):171-87. (PMID: 25979780)
Orphanet J Rare Dis. 2011 Jun 20;6:44. (PMID: 21689452)
Tohoku J Exp Med. 1999 Aug;188(4):317-34. (PMID: 10598689)
Early Hum Dev. 2000 Apr;58(1):41-55. (PMID: 10785335)
فهرسة مساهمة: Keywords: 2-OH-GA, 2-hydroxyglutaric acidemia; 4-OH-BA, 4-hydroxybutyric acidemia; AA, amino acid disorder; ASA, argininosuccinic aciduria; Amino acid disorder; BKTD, β-ketothiolase deficiency; CACT, carnitine-acylcarnitine translocase; CPT1, carnitine palmitoyltransferase I; CPT2, carnitine palmitoyltransferase II; CTLN1, citrullinemia type I; ENBS, expanded newborn screening; Expanded newborn screening; FAOD, fatty acid oxidation disorder; Fatty acid oxidation disorder; GA1, glutaric acidemia type I; GA2, glutaric acidemia type II; GC/MS, gas chromatography–mass spectrometry; HAD, 3-hydoxyacyl-CoA dehydrogenase; HCU, homocystinuria; HMGL, 3-hydroxy-3-methylglutaryl-CoA lyase; HMGS, 3-hydroxy-3-methylglutaryl-CoA synthetase; IMD, inherited metabolic disease; Incidence rate; Inherited metabolic disease; LCHAD, long-chain 3-hydroxyacyl-CoA dehydrogenase; MCAD, medium-chain acyl-CoA dehydrogenase; MCCD, 3-methylcrotonyl-CoA carboxylase deficiency; MCD, multiple carboxylase deficiency; MGA, 3-methylglutaconic aciduria; MMA, methylmalonic acidemia; MS/MS, tandem mass spectrometry; MSUD, maple syrup urine disease; NBS, newborn screening; OA, organic acidemia; OXPA, 5-oxoprolinemia; Organic acidemia; PCD, primary carnitine deficiency; PKU, phenylketonuria; PPA, propionic acidemia; SCAD, short-chain acyl-CoA dehydrogenase; TFP, trifunctional protein; UCD, urea cycle disorder; VLCAD, very long-chain acyl-CoA dehydrogenase
تواريخ الأحداث: Date Created: 20180628 Latest Revision: 20220318
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC6014585
DOI: 10.1016/j.ymgmr.2018.05.003
PMID: 29946514
قاعدة البيانات: MEDLINE
الوصف
تدمد:2214-4269
DOI:10.1016/j.ymgmr.2018.05.003